Scarica l'app Stockscreener
8.49
3.79%
0.31
Dopo l'orario di chiusura:
8.33
-0.16
-1.88%
Precedente Chiudi:
$8.18
Aprire:
$8.05
Volume 24 ore:
60,150
Relative Volume:
0.92
Capitalizzazione di mercato:
$184.21M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
-32.08%
6M Prestazione:
-29.25%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$8.03
$8.50
Intervallo di 1 settimana:
$8.03
$9.09
Portata 52W:
$4.88
$19.58
Aardvark Therapeutics Inc Stock (AARD) Company Profile
Nome
Aardvark Therapeutics Inc
Settore
Industria
Telefono
(858) 225-7696
Indirizzo
4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO
Confronta AARD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AARD
Aardvark Therapeutics Inc
|
8.49 | 192.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-10 | Iniziato | BofA Securities | Buy |
| 2025-03-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-10 | Iniziato | Morgan Stanley | Overweight |
| 2025-03-10 | Iniziato | RBC Capital Mkts | Outperform |
Aardvark Therapeutics Inc Borsa (AARD) Ultime notizie
Is Aardvark Therapeutics Inc. a candidate for recovery play2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Can Aardvark Therapeutics Inc. recover in the next quarterWeekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
How to forecast Aardvark Therapeutics Inc. trends using time seriesMarket Trend Summary & High Accuracy Investment Signals - Newser
Aardvark Therapeutics Updates Corporate Presentation on Strategy - TipRanks
How to build a custom watchlist for Aardvark Therapeutics Inc.2025 Earnings Impact & Accurate Intraday Trading Signals - Newser
Custom watchlist performance reports with Aardvark Therapeutics Inc.Market Activity Summary & Trade Opportunity Analysis - Newser
Tools to assess Aardvark Therapeutics Inc.’s risk profileMarket Volume Report & Safe Swing Trade Setups - Newser
Real time breakdown of Aardvark Therapeutics Inc. stock performanceMarket Sentiment Review & Safe Capital Allocation Plans - Newser
What MACD signals say about Aardvark Therapeutics Inc.Earnings Risk Summary & Detailed Earnings Play Alerts - Newser
Aardvark Therapeutics Inc. stock chart pattern explainedPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Published on: 2025-09-03 01:34:16 - Newser
Can Aardvark Therapeutics Inc. continue delivering strong returns2025 Dividend Review & Trade Opportunity Analysis Reports - khodrobank.com
Published on: 2025-09-03 03:50:21 - Newser
Does Aardvark Therapeutics Inc. offer margin of safetyQuarterly Profit Report & Smart Swing Trading Techniques - khodrobank.com
Should I average down on Aardvark Therapeutics Inc. stockEarnings Beat & Fast Momentum Stock Entry Tips - khodrobank.com
Aardvark Therapeutics Inc. stock daily chart insightsTrade Entry Report & Fast Entry High Yield Stock Tips - Newser
Will Aardvark Therapeutics Inc. bounce back from current supportWeekly Trading Summary & Long-Term Investment Growth Plans - Newser
Is Aardvark Therapeutics Inc. stock a good dividend stockJuly 2025 Update & Growth Focused Entry Reports - khodrobank.com
Will Aardvark Therapeutics Inc. outperform its industry peersOil Prices & Daily Stock Trend Watchlist - khodrobank.com
Analyzing Aardvark Therapeutics Inc. with risk reward ratio chartsMarket Sentiment Review & Safe Capital Allocation Plans - Newser
Is Aardvark Therapeutics Inc. benefiting from innovation trendsJuly 2025 Levels & Weekly Stock Breakout Alerts - khodrobank.com
What are the risks of holding Aardvark Therapeutics Inc.Weekly Investment Report & High Accuracy Trade Signal Alerts - khodrobank.com
Can Aardvark Therapeutics Inc. rally from current levelsJuly 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Published on: 2025-09-01 03:37:33 - Newser
Is Aardvark Therapeutics Inc. stock a smart retirement pickNew Guidance & Safe Entry Momentum Stock Tips - khodrobank.com
Statistical indicators supporting Aardvark Therapeutics Inc.’s strengthTrade Performance Summary & AI Powered Buy/Sell Recommendations - Newser
Does Aardvark Therapeutics Inc. fit your quant trading modelEarnings Recap Report & Verified Chart Pattern Signals - Newser
What’s next for Aardvark Therapeutics Inc. stock priceWeekly Stock Summary & Long-Term Growth Stock Strategies - Newser
How high can Aardvark Therapeutics Inc. stock goJuly 2025 PreEarnings & Stepwise Trade Execution Plans - Newser
How to manage a losing position in Aardvark Therapeutics Inc.2025 Risk Factors & Reliable Breakout Forecasts - Newser
Trendlines Suggest Aardvark Therapeutics Inc. May Bottom Out Soon getLinesFromResByArray error: size == 0 - kangso.co.kr
What high frequency data says about Aardvark Therapeutics Inc.Bear Alert & Real-Time Volume Surge Alerts - Newser
Tick level data insight on Aardvark Therapeutics Inc. volatilityWeekly Profit Report & Community Driven Trade Alerts - Newser
Backtesting results for Aardvark Therapeutics Inc. trading strategiesQuarterly Trade Report & AI Driven Stock Movement Reports - Newser
What Fibonacci levels say about Aardvark Therapeutics Inc. reboundJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - Newser
Aardvark Therapeutics Inc Azioni (AARD) Dati Finanziari
Non sono disponibili dati finanziari per Aardvark Therapeutics Inc (AARD). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Aardvark Therapeutics Inc Azioni (AARD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lee Tien-Li | Chief Executive Officer |
Aug 28 '25 |
Option Exercise |
4.24 |
17,209 |
72,966 |
1,513,384 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):